The investment in internationalization is another of BIAL's main operating guidelines, whose products are in pharmacies in more than 50 countries.
Vaccine production and allergy research are centralized in Spain, in what is one of the world's largest pharmaceutical markets. BIAL Spain employs a team of more than 270 workers. Besides allergology, we market products to treat cardiology and respiratory disorders, as well as drugs for other therapeutic areas.
Our medicinal products are distributed in several markets in Europe, Africa, America and Asia. In order to ensure first rate service in different parts of the globe we also have offices in Italy, Switzerland, Mozambique, Angola, Ivory Coast and Panama.
Albania • Austria • Cyprus • Czech Republic • Denmark • Finland • Germany • Greece • Iceland • Ireland • Italy • Malta • Norway • Portugal • Spain • Sweden • United Kingdom
Costa Rica • Cuba • Dominican Republic • Ecuador • El Salvador • Guatemala • Haiti • Honduras • Nicaragua • Panama • Venezuela
Angola • Benin • Burkina-Faso • Cameroon • Cape Verde • Congo Brazzaville • Dem. Rep. of Congo • Gabon • Guinea Conakry • Ivory Coast • Madagascar • Mali • Mauritania • Mauritius • Mozambique • Niger • República Centroafricana • Senegal • Tchad • Togo
Asia and Middle East
Hong Kong • Lebanon • Macao
We want to boost our position in the markets where we are currently operating, especially in Europe. The commercialization of the fruits of BIAL's research will be an added impetus to our international expansion, helping us to be better able to serve your Health.